Device Trial Radar · NCT01802203
trūFreeze® Spray Cryotherapy Patient Registry
Last checked: Nov 19, 2026Latest source record: Jul 25, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
275
Actual
Start
Apr 2013
Primary completion
Jan 2022
Study completion Apr 2022
Sponsor
- Lead sponsor
- US Endoscopy Group Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 1, 2013
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To collect efficacy and outcomes data related to the use of trūFreeze® spray cryotherapy for the treatment of unwanted tissue in the pulmonary and gastrointestinal settings.
Conditions
- Barrett Esophagus
- Esophageal Dysplasia
- Esophageal Neoplasm
- Esophageal Stenosis
- Bronchial Neoplasm
- Stenosis of Bronchus or Trachea
Interventions
truFreeze Spray CryotherapyDevice
spray cryotherapy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Collect efficacy and outcome data related to the use of trūFreeze® spray cryotherapy for treatment of unwanted tissue in the pulmonary and gastrointestinal settings.Time frame: 5 years
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Scripps Green Hosptial
La Jolla, California
University of Colorado Denver
Denver, Colorado
Borland-Groover Clinic
Jacksonville, Florida
13 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.